我院2001～2004年口服抗糖尿病药物应用分析  

Analysis of the use of the oral antidiabetic agents in our hospital from 2001 to 2004

作　　者：郑琰[1] 盛蓉[1] 范世忠[1] 

机构地区：[1]成都中医药大学附属医院,四川成都610072

出　　处：《药品评价》2005年第5期366-368,共3页Drug Evaluation

摘　　要：目的了解我院口服抗糖尿病药的用药情况及发展趋势,为临床合理用药提供参考。方法采用金额排序法和频度分析法对我院2001～2004年口服抗糖尿病药物应用情况进行统计分析。结果我院口服抗糖尿病药物用药金额2004年是2001年的3.58倍,用药频率2004年是2001年的2.22倍,以阿卡波糖、格列吡嗪、格列齐特、格列喹酮和盐酸二甲双胍的临床使用为最多。结论口服抗糖尿病药在2型糖尿病的临床治疗中占有重要地位。该类药物近年来发展较快,合理用药十分重要。Objective To investigate a using situation and developing trend of the oral antidia- betic agents, in order to provide reference for clinic druguse. Methods To analyze and sum up the use of the oral antidiabetic agents in our hospital from 2001 to 2004 by using the methods of DDDs analysis and ranking of amount of money. Results Sum of money for drug consumption of the oral antidiabetic agents in our hospital in 2004 was 3.58 times of those in 2001, DDDs in 2004 was 2.22times of that in 2001. The sum of money of Acarbose,Glipizide,Gliclazide, Gliquidone and Metformin Hydrochloride was larger in clinical application. Conclusion The oral antidiabetic agents play an important role in the chnical treatment of the type 2 diabetes. The oral antidiabetic agents are developed very fast in recent years, it is very important to use medicine rationally.

关 键 词：抗糖尿病药 限定日剂量 用药金额 用药频度 用药分析 

分 类 号：R96[医药卫生—药理学]